The recent inflation report came in cooler than expected at 2.8% in February, from 3% in January. It’s still higher than the Federal Reserve’s...
Garrett Baldwin picks out an energy stock with huge upside potential and gives an overview of market...
If dividend stocks provide investors with predictable income, then DRIP stocks offer significant long-term growth potential.
As a result,...
There’s no better time than now to invest in dividend stocks.
And some of the best dividend stocks that beat the S&P 500’s average yield...
Some market-leading biotech firms are working hard right now developing drugs derived from cannabis' many beneficial compounds.
And there's...
Our Shah Gilani calls this time "The Era of the Income-Challenged Investor."
And with good reason.
Fed policymakers just voted...
High-yield dividend stocks typically carry some risk, but the devastating impact of the coronavirus on the economy has upset an otherwise sound...
The Dow Jones Industrial Average is coming off its sharpest drop into a bear market in history this month.
The ongoing coronavirus...
My colleague Keith Fitz-Gerald told you yesterday how we could see a 3% to 5% market drop as more coronavirus news comes out. The...
If you're an income-seeking investor trying to maximize returns, the best dividend stocks to buy could be your...
The Dow Jones today is heading for a flat morning as traders wait to hear from Federal Reserve Chair Jerome Powell.
The head of the U.S....
Investors seeking to buy high-yield dividend stocks need to know where to look.
With market conditions mimicking pre-recession - an...
Investors are always seeking the secret weapon to help them achieve life-changing gains.
You can search forever for new strategies, but...
Eager investors are hoping the Lyft IPO will be their next opportunity for market-beating gains this year.
Unfortunately, you won't be...
By 2025, the biotech industry will be worth will be $727 billion - a 120% increase over its total value in 2015.
To help you take...
Stocks have been flat this year, but that doesn't mean sharp traders aren't making money hand over fist. After all, we're still in the middle of...
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop...
AbbVie Inc., a biotech stock we like, took a hit last week following disappointing mid-phase trial results for one of its pipeline...
We start off our latest list of best stocks to buy now with two smart plays on cryptocurrencies and blockchain technology.
Plus, we've...
The Dow Jones Today futures were down slightly in pre-market trading as markets continue to digest recent indications of rising...
